BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31112530)

  • 1. Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer.
    Sivaram N; McLaughlin PA; Han HV; Petrenko O; Jiang YP; Ballou LM; Pham K; Liu C; van der Velden AW; Lin RZ
    J Clin Invest; 2019 May; 129(8):3264-3276. PubMed ID: 31112530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.
    Rataj F; Kraus FBT; Chaloupka M; Grassmann S; Heise C; Cadilha BL; Duewell P; Endres S; Kobold S
    Front Immunol; 2018; 9():1955. PubMed ID: 30214445
    [No Abstract]   [Full Text] [Related]  

  • 3. T-Cell-Specific Loss of the PI-3-Kinase p110α Catalytic Subunit Results in Enhanced Cytokine Production and Antitumor Response.
    Aragoneses-Fenoll L; Ojeda G; Montes-Casado M; Acosta-Ampudia Y; Dianzani U; Portolés P; Rojo JM
    Front Immunol; 2018; 9():332. PubMed ID: 29535720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors.
    Tateishi K; Nakamura T; Juratli TA; Williams EA; Matsushita Y; Miyake S; Nishi M; Miller JJ; Tummala SS; Fink AL; Lelic N; Koerner MVA; Miyake Y; Sasame J; Fujimoto K; Tanaka T; Minamimoto R; Matsunaga S; Mukaihara S; Shuto T; Taguchi H; Udaka N; Murata H; Ryo A; Yamanaka S; Curry WT; Dias-Santagata D; Yamamoto T; Ichimura K; Batchelor TT; Chi AS; Iafrate AJ; Wakimoto H; Cahill DP
    Clin Cancer Res; 2019 Jul; 25(14):4375-4387. PubMed ID: 30975663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell-Derived IL35 Drives STAT3-Dependent CD8
    Mirlekar B; Michaud D; Lee SJ; Kren NP; Harris C; Greene K; Goldman EC; Gupta GP; Fields RC; Hawkins WG; DeNardo DG; Rashid NU; Yeh JJ; McRee AJ; Vincent BG; Vignali DAA; Pylayeva-Gupta Y
    Cancer Immunol Res; 2020 Mar; 8(3):292-308. PubMed ID: 32024640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses.
    Watanabe K; Luo Y; Da T; Guedan S; Ruella M; Scholler J; Keith B; Young RM; Engels B; Sorsa S; Siurala M; Havunen R; Tähtinen S; Hemminki A; June CH
    JCI Insight; 2018 Apr; 3(7):. PubMed ID: 29618658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway.
    Shi P; Yin T; Zhou F; Cui P; Gou S; Wang C
    BMC Cancer; 2014 May; 14():370. PubMed ID: 24885711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma.
    Ryschich E; Nötzel T; Hinz U; Autschbach F; Ferguson J; Simon I; Weitz J; Fröhlich B; Klar E; Büchler MW; Schmidt J
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):498-504. PubMed ID: 15701833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer.
    Bengsch F; Knoblock DM; Liu A; McAllister F; Beatty GL
    Cancer Immunol Immunother; 2017 Dec; 66(12):1609-1617. PubMed ID: 28856392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of defective CD4-CD8- T cells in murine tumors generated independent of antigen specificity.
    Prins RM; Incardona F; Lau R; Lee P; Claus S; Zhang W; Black KL; Wheeler CJ
    J Immunol; 2004 Feb; 172(3):1602-11. PubMed ID: 14734741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of HLA class I/II antigens and T cell immune response in human neuroendocrine tumors of the pancreas.
    Ryschich E; Autschbach F; Eisold S; Klar E; Buchler MW; Schmidt J
    Tissue Antigens; 2003 Jul; 62(1):48-54. PubMed ID: 12859594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis.
    Kennedy AL; Morton JP; Manoharan I; Nelson DM; Jamieson NB; Pawlikowski JS; McBryan T; Doyle B; McKay C; Oien KA; Enders GH; Zhang R; Sansom OJ; Adams PD
    Mol Cell; 2011 Apr; 42(1):36-49. PubMed ID: 21474066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN loss correlates with T cell exclusion across human cancers.
    Lin Z; Huang L; Li SL; Gu J; Cui X; Zhou Y
    BMC Cancer; 2021 Apr; 21(1):429. PubMed ID: 33874915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.
    Okudaira K; Hokari R; Tsuzuki Y; Okada Y; Komoto S; Watanabe C; Kurihara C; Kawaguchi A; Nagao S; Azuma M; Yagita H; Miura S
    Int J Oncol; 2009 Oct; 35(4):741-9. PubMed ID: 19724910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity.
    Yang X; Chu Y; Wang Y; Zhang R; Xiong S
    J Leukoc Biol; 2006 Dec; 80(6):1434-44. PubMed ID: 16980511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local Phototherapy Synergizes with Immunoadjuvant for Treatment of Pancreatic Cancer through Induced Immunogenic Tumor Vaccine.
    Zhou F; Yang J; Zhang Y; Liu M; Lang ML; Li M; Chen WR
    Clin Cancer Res; 2018 Nov; 24(21):5335-5346. PubMed ID: 30068705
    [No Abstract]   [Full Text] [Related]  

  • 18. TREM-2 mediated signaling induces antigen uptake and retention in mature myeloid dendritic cells.
    Radhakrishnan S; Arneson LN; Upshaw JL; Howe CL; Felts SJ; Colonna M; Leibson PJ; Rodriguez M; Pease LR
    J Immunol; 2008 Dec; 181(11):7863-72. PubMed ID: 19017976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model.
    Oflazoglu E; Elliott M; Takita H; Ferrone S; Henderson RA; Repasky EA
    J Transl Med; 2007 Jun; 5():29. PubMed ID: 17592641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA Mutation.
    Fang DD; Zhang CC; Gu Y; Jani JP; Cao J; Tsaparikos K; Yuan J; Thiel M; Jackson-Fisher A; Zong Q; Lappin PB; Hayashi T; Schwab RB; Wong A; John-Baptiste A; Bagrodia S; Los G; Bender S; Christensen J; Vanarsdale T
    PLoS One; 2013; 8(6):e67258. PubMed ID: 23826249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.